Our trustees provide vital leadership and direction for our charity, ensuring we operate effectively and stay true to our mission. In addition to guiding our organisation, they actively participate in our fundraisers and official Lily events.
Our board bring a diverse range of expertise, from HR and commercial acumen to legal insight, and their combined knowledge is invaluable in helping us make a meaningful impact on those affected by mitochondrial disease.
Rupinder Bains
Director, Lead Safeguarding Trustee
“I’m Rupinder, the Managing Director of Pinder Reaux & Associates Ltd (a specialist media and sports law firm), and I began working for this amazing charity in the capacity of legal adviser. I was then honoured to be invited on to the Board of Directors to work with a strong, determined and dedicated team, helping families suffering from mitochondrial disease. Whilst being a solicitor and heading up my own company pretty much takes up most of my life, what spare time I do have I spend with my husband and two children.”
Helen Rider
Director
“I’m a Managing Director within the financial services industry and, more importantly, I’m Lily’s auntie. After Lily was born, our family experienced some of the saddest and most difficult times. I was inspired by the strength of my tiny niece Lily, who in her short life fought against her fate to teach us about courage – that no matter how little time we have, we can make a huge impact if we try. Lily’s spirit has lived on and The Lily Foundation is a ‘can do’ charity who has taken on the unknown and is winning.”
Dean Curtis
Director
“Hello, I’m Dean and I work as CEO of a division of RELX Group, a FTSE 20 global provider of information-based analytics and decision tools. I’ve enjoyed a career in football, banking, data and technology, and love building and working within high performance teams who make a difference. Lily is exactly that, and after meeting Liz and the team I wanted to do all I could to help them provide funding for research, educate and raise awareness of mitochondrial disease, in addition to supporting families when they need it most. The Lily family is large, ever-expanding and making a huge difference at a crucial time.”